Extracellular ATP released by osteoblasts is a key local inhibitor of bone mineralisation.

Previous studies have shown that exogenous ATP (>1 µM) prevents bone formation in vitro by blocking mineralisation of the collagenous matrix. This effect is thought to be mediated via both P2 receptor-dependent pathways and a receptor-independent mechanism (hydrolysis of ATP to produce the minera...

Full description

Bibliographic Details
Main Authors: Isabel R Orriss, Michelle L Key, Mark O R Hajjawi, Timothy R Arnett
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2013-01-01
Series:PLoS ONE
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/23874866/pdf/?tool=EBI
id doaj-777578988f9745a3954f8f5e6e2a260d
record_format Article
spelling doaj-777578988f9745a3954f8f5e6e2a260d2021-03-04T12:36:14ZengPublic Library of Science (PLoS)PLoS ONE1932-62032013-01-0187e6905710.1371/journal.pone.0069057Extracellular ATP released by osteoblasts is a key local inhibitor of bone mineralisation.Isabel R OrrissMichelle L KeyMark O R HajjawiTimothy R ArnettPrevious studies have shown that exogenous ATP (>1 µM) prevents bone formation in vitro by blocking mineralisation of the collagenous matrix. This effect is thought to be mediated via both P2 receptor-dependent pathways and a receptor-independent mechanism (hydrolysis of ATP to produce the mineralisation inhibitor pyrophosphate, PP(i)). Osteoblasts are also known to release ATP constitutively. To determine whether this endogenous ATP might exert significant biological effects, bone-forming primary rat osteoblasts were cultured with 0.5-2.5 U/ml apyrase (which sequentially hydrolyses ATP to ADP to AMP + 2 P(i)). Addition of 0.5 U/ml apyrase to osteoblast culture medium degraded extracellular ATP to <1% of control levels within 2 minutes; continuous exposure to apyrase maintained this inhibition for up to 14 days. Apyrase treatment for the first 72 hours of culture caused small decreases (≤25%) in osteoblast number, suggesting a role for endogenous ATP in stimulating cell proliferation. Continuous apyrase treatment for 14 days (≥0.5 U/ml) increased mineralisation of bone nodules by up to 3-fold. Increases in bone mineralisation were also seen when osteoblasts were cultured with the ATP release inhibitors, NEM and brefeldin A, as well as with P2X1 and P2X7 receptor antagonists. Apyrase decreased alkaline phosphatase (TNAP) activity by up to 60%, whilst increasing the activity of the PP(i)-generating ecto-nucleotide pyrophosphatase/phosphodiesterases (NPPs) up to 2.7-fold. Both collagen production and adipocyte formation were unaffected. These data suggest that nucleotides released by osteoblasts in bone could act locally, via multiple mechanisms, to limit mineralisation.https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/23874866/pdf/?tool=EBI
collection DOAJ
language English
format Article
sources DOAJ
author Isabel R Orriss
Michelle L Key
Mark O R Hajjawi
Timothy R Arnett
spellingShingle Isabel R Orriss
Michelle L Key
Mark O R Hajjawi
Timothy R Arnett
Extracellular ATP released by osteoblasts is a key local inhibitor of bone mineralisation.
PLoS ONE
author_facet Isabel R Orriss
Michelle L Key
Mark O R Hajjawi
Timothy R Arnett
author_sort Isabel R Orriss
title Extracellular ATP released by osteoblasts is a key local inhibitor of bone mineralisation.
title_short Extracellular ATP released by osteoblasts is a key local inhibitor of bone mineralisation.
title_full Extracellular ATP released by osteoblasts is a key local inhibitor of bone mineralisation.
title_fullStr Extracellular ATP released by osteoblasts is a key local inhibitor of bone mineralisation.
title_full_unstemmed Extracellular ATP released by osteoblasts is a key local inhibitor of bone mineralisation.
title_sort extracellular atp released by osteoblasts is a key local inhibitor of bone mineralisation.
publisher Public Library of Science (PLoS)
series PLoS ONE
issn 1932-6203
publishDate 2013-01-01
description Previous studies have shown that exogenous ATP (>1 µM) prevents bone formation in vitro by blocking mineralisation of the collagenous matrix. This effect is thought to be mediated via both P2 receptor-dependent pathways and a receptor-independent mechanism (hydrolysis of ATP to produce the mineralisation inhibitor pyrophosphate, PP(i)). Osteoblasts are also known to release ATP constitutively. To determine whether this endogenous ATP might exert significant biological effects, bone-forming primary rat osteoblasts were cultured with 0.5-2.5 U/ml apyrase (which sequentially hydrolyses ATP to ADP to AMP + 2 P(i)). Addition of 0.5 U/ml apyrase to osteoblast culture medium degraded extracellular ATP to <1% of control levels within 2 minutes; continuous exposure to apyrase maintained this inhibition for up to 14 days. Apyrase treatment for the first 72 hours of culture caused small decreases (≤25%) in osteoblast number, suggesting a role for endogenous ATP in stimulating cell proliferation. Continuous apyrase treatment for 14 days (≥0.5 U/ml) increased mineralisation of bone nodules by up to 3-fold. Increases in bone mineralisation were also seen when osteoblasts were cultured with the ATP release inhibitors, NEM and brefeldin A, as well as with P2X1 and P2X7 receptor antagonists. Apyrase decreased alkaline phosphatase (TNAP) activity by up to 60%, whilst increasing the activity of the PP(i)-generating ecto-nucleotide pyrophosphatase/phosphodiesterases (NPPs) up to 2.7-fold. Both collagen production and adipocyte formation were unaffected. These data suggest that nucleotides released by osteoblasts in bone could act locally, via multiple mechanisms, to limit mineralisation.
url https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/23874866/pdf/?tool=EBI
work_keys_str_mv AT isabelrorriss extracellularatpreleasedbyosteoblastsisakeylocalinhibitorofbonemineralisation
AT michellelkey extracellularatpreleasedbyosteoblastsisakeylocalinhibitorofbonemineralisation
AT markorhajjawi extracellularatpreleasedbyosteoblastsisakeylocalinhibitorofbonemineralisation
AT timothyrarnett extracellularatpreleasedbyosteoblastsisakeylocalinhibitorofbonemineralisation
_version_ 1714802148208803840